Afuco™ Anti-Human Laminin-332 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-Laminin-332 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies against various domains of laminin-332 reduce the adhesion and matrix binding properties of laminin-332, inhibiting tumor growth and metastasis in vivo. LN-332 is up-regulated in various epithelial cancers, including colon, gastric, mammary duct and squamous cell carcinomas, as well as melanomas, but not in mesenchymal cancers.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-461CL |
| Pricing | Inquiry |
| Host | Human |
| Target | Laminin-332 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C. |